<?xml version="1.0" encoding="ISO-8859-1"?>
<!DOCTYPE rss PUBLIC "-//Netscape Communications//DTD RSS 0.91//EN"
        "http://ww1.prweb.com/rss091.dtd">


<rss version="0.91">
  <channel>
    <title>PRWeb: Technology  Biotechnology</title>
    <link>http://www.prweb.com</link>
    <description>Latest news releases for Technology  Biotechnology from PRWeb</description>
    <language>en</language>
    <image>
      <title>PRWeb Distribution Newswire</title>
      <url>http://www.prweb.com/images_v4/prweb_logo_hv2.jpg</url>
      <link>http://www.prweb.com</link>
      <width>200</width>
      <height>46</height>
    </image>
    <managingEditor>xml@emediawire.com</managingEditor>
    <webMaster>xml@emediawire.com</webMaster>

<item>
    <title>NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont&#174; </title>
    <link>http://www.prweb.com/releases/2009/12/prweb3313064.htm</link>
    <description>
        <![CDATA[  <P>The National Eye Institute (NEI), a division of the National Institutes of Health (NIH), awarded a $2.18 million grant to Aciont Inc. to help fund its development of a non-invasive, passive diffusion-based treatment for severe, non-infectious uveitis.   (PRWeb Dec 10, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/12/prweb3313064.htm">http://www.prweb.com/releases/2009/12/prweb3313064.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner </title>
    <link>http://www.prweb.com/releases/life-line-screening/vascular-disease/prweb3318514.htm</link>
    <description>
        <![CDATA[  <P>The Vascular Disease Foundation has a new partner and sponsor in Life Line Screening. The two companies aim to further educate the population about vascular disease and vascular testing services like abdominal aortic aneurysm (http://www.lifelinescreening.com/screeningservices/Pages/AbdominalAorticAneurysm.aspx) and peripheral arterial disease screening (http://www.lifelinescreening.com/screeningservices/Pages/PeripheralArterialDisease.aspx). Life Line Screening will distribute the foundation&#8217;s educational publications and provide online registration so that its customers can easily donate money to the foundation. (PRWeb Dec 10, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/life-line-screening/vascular-disease/prweb3318514.htm">http://www.prweb.com/releases/life-line-screening/vascular-disease/prweb3318514.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Martek Signs Sole-Source Supply Agreement with Fonterra</title>
    <link>http://www.prweb.com/releases/dairy_fonterra/martek_biosciences/prweb3321614.htm</link>
    <description>
        <![CDATA[  <P>Martek Biosciences Corporation (http://www.martek.com/) (NASDAQ: MATK) announced today that it has entered into a multi-year, sole-source supply agreement with leading global dairy company Fonterra Co-operative Group Limited for the use of Martek&#8217;s products in Fonterra&#8217;s infant formulas and milk-based Anmum&#8482; Materna products for pregnant and nursing mothers. (PRWeb Dec 10, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/dairy_fonterra/martek_biosciences/prweb3321614.htm">http://www.prweb.com/releases/dairy_fonterra/martek_biosciences/prweb3321614.htm</a></P>]]>
    </description>
</item>
<item>
    <title>La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert </title>
    <link>http://www.prweb.com/releases/2009LaJolla/12Adamis/prweb3316754.htm</link>
    <description>
        <![CDATA[  <P>La Jolla Pharmaceutical value debate is raging on as investors consider the facts in the merger agreement with Adamis Pharmaceuticals Corp.  Some investors have stated in a TapeBeat.Com discussion thread that the value is to be decided by the market while other say simple math proves the value was set in the merger agreement. (PRWeb Dec 10, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009LaJolla/12Adamis/prweb3316754.htm">http://www.prweb.com/releases/2009LaJolla/12Adamis/prweb3316754.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Brooks Instrument Appoints Mike Bayda as Global Level Product Manager </title>
    <link>http://www.prweb.com/releases/2009/12/prweb3321194.htm</link>
    <description>
        <![CDATA[  <P>Brooks Instrument, a world-leading provider of advanced flow measurement, control, and level solutions, announced that Mike Bayda will join the company as Global Level Product Manager effective November 30, 2009. He will lead Brooks Instrument&#8217;s efforts to enhance market penetration of the level measurement products around the world. He is joining Brooks Instrument from Lafarge Corp, a manufacturer of building materials, where he served as Director of Marketing and Sales. Bayda will report to Brooks Instrument Vice President Tim Scott. (PRWeb Dec 10, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/12/prweb3321194.htm">http://www.prweb.com/releases/2009/12/prweb3321194.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years</title>
    <link>http://www.prweb.com/releases/2009/12/prweb3322104.htm</link>
    <description>
        <![CDATA[  <P>The ACHDC was the first medical center in the country specifically established to treat adolescents and adults and is today the largest of its kind in California.  Today, the ACHDC has more than 3,000 patients in its registry. (PRWeb Dec 10, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/12/prweb3322104.htm">http://www.prweb.com/releases/2009/12/prweb3322104.htm</a></P>]]>
    </description>
</item>
<item>
    <title>New England Peptide Unveils Proprietary Large Scale Peptide Synthesizer; PepScale&#8482; Synthesizer Facilitates Cost-Effective Scale Up </title>
    <link>http://www.prweb.com/releases/2009/12/prweb3325834.htm</link>
    <description>
        <![CDATA[  <P>New England Peptide (NEP) today announced the introduction of a proprietary peptide synthesis instrument, PepScale&#8482;, to better enable peptide scale-up and process development projects for its customers. PepScale&#8482; was designed by NEP&#039;s in-house development team to provide the flexibility required for development work while taking advantage of the process efficiencies for which NEP has become known.  (PRWeb Dec 10, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/12/prweb3325834.htm">http://www.prweb.com/releases/2009/12/prweb3325834.htm</a></P>]]>
    </description>
</item>
<item>
    <title>RURO Introduces RFID, Facilitating Frozen Sample Storage</title>
    <link>http://www.prweb.com/releases/2009/12/prweb3316124.htm</link>
    <description>
        <![CDATA[  <P>RURO Inc., a leading developer of innovative research productivity tools, introduces RFID (radio-frequency identification) component for its FreezerPro&#174; frozen sample management system. RFID-enabled FreezerPro creates transparent frozen sample storage with always up-to-date map and flexible search, ensures better sample preservation with samples never leaving freezers unless used, and makes access control management and storage audits inherently easy. (PRWeb Dec 10, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/12/prweb3316124.htm">http://www.prweb.com/releases/2009/12/prweb3316124.htm</a></P>]]>
    </description>
</item>
<item>
    <title>MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products</title>
    <link>http://www.prweb.com/releases/Genedata_MEDINA/kinetics_assay_screening/prweb3305024.htm</link>
    <description>
        <![CDATA[  <P>Spanish Public-private Foundation for Life Sciences Research Adopts the Genedata Screener&#174; 7.0 Data Management Platform for High Throughput and High Content Screening. (PRWeb Dec 9, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/Genedata_MEDINA/kinetics_assay_screening/prweb3305024.htm">http://www.prweb.com/releases/Genedata_MEDINA/kinetics_assay_screening/prweb3305024.htm</a></P>]]>
    </description>
</item>
<item>
    <title>CSOFT&#8217;s MedL10N Hires Beckman Coulter Veteran Tammy Werner   </title>
    <link>http://www.prweb.com/releases/2009/CSOFTTammyWerner/prweb3310024.htm</link>
    <description>
        <![CDATA[  <P>Werner Brings 15+ Years Experience to CSOFT&#8217;s Life Sciences Division (PRWeb Dec 9, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/CSOFTTammyWerner/prweb3310024.htm">http://www.prweb.com/releases/2009/CSOFTTammyWerner/prweb3310024.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Olympics 2016, World Cup 2014, But First &#8211; Adventus Brasil 2009</title>
    <link>http://www.prweb.com/releases/groundwater/contaminated_soil/prweb3313614.htm</link>
    <description>
        <![CDATA[  <P>Remediation biotechnology firm announces opening of its Brazilian regional office (PRWeb Dec 9, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/groundwater/contaminated_soil/prweb3313614.htm">http://www.prweb.com/releases/groundwater/contaminated_soil/prweb3313614.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Customize Your Advanced Bionics Sound Processors With Eye-Catching Looks From Skinit</title>
    <link>http://www.prweb.com/releases/2009/12/prweb3309544.htm</link>
    <description>
        <![CDATA[  <P>Decorative designs available just in time for the holidays (PRWeb Dec 9, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/12/prweb3309544.htm">http://www.prweb.com/releases/2009/12/prweb3309544.htm</a></P>]]>
    </description>
</item>
<item>
    <title>RURO Launches Sciency - Secure Web-based Integrated Research Environment</title>
    <link>http://www.prweb.com/releases/2009/12/prweb3310354.htm</link>
    <description>
        <![CDATA[  <P>RURO Inc., a leading developer of innovative research productivity tools, announces the release of Sciency&#174;, new generation ELN (Electronic Lab Notebook). Beyond just &quot;going paperless&quot;, Sciency creates scalable, integrated research environment, enabling secure data sharing, project management, and interaction with existing systems and databases. Sciency is 21 CFR Part 11 compliant for use in regulated industries, such as medical devices or pharmaceuticals. (PRWeb Dec 9, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/12/prweb3310354.htm">http://www.prweb.com/releases/2009/12/prweb3310354.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Nutra Pharma Completes FDA Submission for Nyloxin OTC and Nyloxin Rx -- Over-the-Counter and Prescription Treatments for Chronic Pain</title>
    <link>http://www.prweb.com/releases/NutraPharma/Nyloxin/prweb3304624.htm</link>
    <description>
        <![CDATA[  <P>Nutra Pharma has completed submission of the final Nyloxin OTC and Nyloxin Rx packaging and labeling to the Food and Drug Administration (FDA). This registration is considered the final step required by the FDA to begin selling Nyloxin OTC and Nyloxin Rx in the United States for the treatment of chronic pain. (PRWeb Dec 8, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/NutraPharma/Nyloxin/prweb3304624.htm">http://www.prweb.com/releases/NutraPharma/Nyloxin/prweb3304624.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Life Science And Medical Device Software Engineering Consulting Firm Full Spectrum Software Announces 12 New Contract Wins In 2009</title>
    <link>http://www.prweb.com/releases/2009gene/11sequencing/prweb3258174.htm</link>
    <description>
        <![CDATA[  <P>Full Spectrum Software achieves another year of record growth with the addition of 12 major new clients. The range of new clients included cutting edge, VC backed start-ups to the some of the largest medical device makers in the world. Their software technologies were equally diverse, including technologies such as nanofluidics, gene sequencing, radiation therapy, novel EEG systems, specialized web services and image guided surgical planning systems. (PRWeb Dec 8, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009gene/11sequencing/prweb3258174.htm">http://www.prweb.com/releases/2009gene/11sequencing/prweb3258174.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Lyric&#174; Presents the Sounds of the Season</title>
    <link>http://www.prweb.com/releases/2009/12/prweb3310604.htm</link>
    <description>
        <![CDATA[  <P>Take Joy in Holiday Festivities This Winter with Lyric, World&#8217;s First Invisible Extended Wear Hearing Aid. (PRWeb Dec 8, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/12/prweb3310604.htm">http://www.prweb.com/releases/2009/12/prweb3310604.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Breakthrough TriPollar&#174; Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures </title>
    <link>http://www.prweb.com/releases/pollogen/anti-aging/prweb3281804.htm</link>
    <description>
        <![CDATA[  <P>Pollogen received ANVISA approval to market the TriPollar&#174; Technology- the most advanced 3rd generation Radio Frequency solution for facial and body contouring.  TriPollar&#174;  anti-aging products have been clinically proven the world over to be safe and effective on all skin types. The treatment is completely painless and non-invasive and patients enjoy visible results from the very 1st treatment.  Long term results are achieved by undergoing a series of treatments.   (PRWeb Dec 7, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/pollogen/anti-aging/prweb3281804.htm">http://www.prweb.com/releases/pollogen/anti-aging/prweb3281804.htm</a></P>]]>
    </description>
</item>
<item>
    <title>New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director </title>
    <link>http://www.prweb.com/releases/2009/12/prweb3299424.htm</link>
    <description>
        <![CDATA[  <P>Following a two-month transition, Paul Pomerantz, MBA, CAE, officially has begun his work as the new worldwide executive director of the Drug Information Association (DIA). (PRWeb Dec 7, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/12/prweb3299424.htm">http://www.prweb.com/releases/2009/12/prweb3299424.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. </title>
    <link>http://www.prweb.com/releases/2009/12MerrimackHermes/prweb3302594.htm</link>
    <description>
        <![CDATA[  <P>Acquisition broadens Merrimack&#8217;s capabilities to discover and develop systems biology-driven therapeutics to include small molecules, chemotherapy and RNAi candidates and technologies for cancer (PRWeb Dec 7, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/12MerrimackHermes/prweb3302594.htm">http://www.prweb.com/releases/2009/12MerrimackHermes/prweb3302594.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Surety Leads Web Symposium to Address Data Integrity Issues in Bio-Sciences Industry</title>
    <link>http://www.prweb.com/releases/2009/12/prweb3308494.htm</link>
    <description>
        <![CDATA[  <P>Surety Leads Web Symposium to Address Data Integrity Issues in Bio-Sciences Industry (PRWeb Dec 7, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/12/prweb3308494.htm">http://www.prweb.com/releases/2009/12/prweb3308494.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Cancer Centers Renew and Expand BioDiscovery&#039;s Nexus Copy Number Software Licenses </title>
    <link>http://www.prweb.com/releases/2009/12/prweb3300524.htm</link>
    <description>
        <![CDATA[  <P>Leading cancer centers including Fox Chase Cancer Center&#039;s Keystone Program in Blood Cell Development and Cancer, the City of Hope Comprehensive Cancer Center, and the National Cancer Institute renew and expand licenses to BioDiscovery&#039;s Nexus Copy Number software.  (PRWeb Dec 7, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/12/prweb3300524.htm">http://www.prweb.com/releases/2009/12/prweb3300524.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Nutra Pharma Announces Upcoming Webinar to Discuss the Company&#8217;s Over-the-Counter (OTC) and Prescription Treatments for Chronic Pain</title>
    <link>http://www.prweb.com/releases/Nutra_Pharma/chronic_pain/prweb3292834.htm</link>
    <description>
        <![CDATA[  <P>Nutra Pharma will be conducting a webinar on December 10, 2009, to discuss the Company&#8217;s over-the-counter and prescription treatments for chronic pain, Cobroxin and Nyloxin Rx. (PRWeb Dec 4, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/Nutra_Pharma/chronic_pain/prweb3292834.htm">http://www.prweb.com/releases/Nutra_Pharma/chronic_pain/prweb3292834.htm</a></P>]]>
    </description>
</item>
<item>
    <title>InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery </title>
    <link>http://www.prweb.com/releases/2009/12/prweb3298024.htm</link>
    <description>
        <![CDATA[  <P> InhibOx, a leading developer of novel and effective computational methods for drug discovery, has joined forces with MolPort, an innovator in rare chemical trading.MolPort focuses on developing rare chemical trading platform and builds database of commercially available compounds. Now we provide this database and its updates to computational chemists at InhibOx where they incorporate it into the virtual screening procedures. Once they identify suitable lead candidates, MolPort offers to efficiently source these compounds and deliver to the client for testing. (PRWeb Dec 4, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/12/prweb3298024.htm">http://www.prweb.com/releases/2009/12/prweb3298024.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Polestar Technologies Improves the Measurement of pH</title>
    <link>http://www.prweb.com/releases/2009/12/prweb3289314.htm</link>
    <description>
        <![CDATA[  <P>Polestar Technologies, a leader in sensor research, technology and product development, announces a dramatically improved optical sensing film for measuring pH.  Long term stability has been a challenge for all techniques used to measure pH.  Polestar&#8217;s new pH sensor has less than 0.1 pH units of drift over 2 months at a 10sec. sampling rate.  This stability is equal to, or better than, any commercially available method for measuring pH. The new sensor also measures over a broad range of pH (5.5 to 10 pH units), has a high level of delivered accuracy (0.05 pH units), and a long lifespan (7M measurements).   (PRWeb Dec 4, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/12/prweb3289314.htm">http://www.prweb.com/releases/2009/12/prweb3289314.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Heidelberg Instruments, GmbH, Receives Order for an Advanced Maskless Lithography System from Japan </title>
    <link>http://www.prweb.com/releases/2009/12/prweb3282304.htm</link>
    <description>
        <![CDATA[  <P>Heidelberg Instruments, GmbH, Heidelberg, Germany, a leading supplier of direct write laser lithography systems, announced the repeat order for an advanced maskless lithography system by Toyo Precision Parts MFG. Co., Ltd, Japan.  This system will be used for production of photomasks used in discrete semiconductors, encoder disks, MEMS, liquid crystal displays, electroluminescence and PDP. (PRWeb Dec 3, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/12/prweb3282304.htm">http://www.prweb.com/releases/2009/12/prweb3282304.htm</a></P>]]>
    </description>
</item>
<item>
    <title>The Scientist Names Photometrics&#8217; Evolve EMCCD Camera One of the &#8220;Top 10 Innovations&#8221; of 2009</title>
    <link>http://www.prweb.com/releases/2009/12/prweb3286874.htm</link>
    <description>
        <![CDATA[  <P>The Scientist, a leading scientific magazine covering the life sciences, ranked Photometrics&#8217; Evolve &#8220;Intelligent&#8221; EMCCD camera fourth among the publication&#8217;s &#8220;Top 10 Innovations of 2009. (PRWeb Dec 2, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/12/prweb3286874.htm">http://www.prweb.com/releases/2009/12/prweb3286874.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Medical Device Software Engineering Consulting firm Full Spectrum Software Earns ISO 13485 Certification</title>
    <link>http://www.prweb.com/releases/2009ISO/1113485/prweb3240284.htm</link>
    <description>
        <![CDATA[  <P>Leading medical device software engineering consulting firm Full Spectrum Software has received ISO 13485 certification. A relatively few medical device software engineering consulting firms have actually achieved ISO 13485 certification. Many medical device makers have ISO 13485 certification and adhere to other ISO standards as well. However, it is somewhat rare for a medical device software engineering consulting firm to achieve the rigorous quality standards and design a Quality Management System required to achieve ISO 13485 certification. (PRWeb Dec 2, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009ISO/1113485/prweb3240284.htm">http://www.prweb.com/releases/2009ISO/1113485/prweb3240284.htm</a></P>]]>
    </description>
</item>
<item>
    <title>EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology</title>
    <link>http://www.prweb.com/releases/tregitope/protein_therapeutics/prweb3283064.htm</link>
    <description>
        <![CDATA[  <P>EpiVax, Inc. today announced a collaborative research agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY) aimed at evaluating EpiVax&#8217;s proprietary Tregitope technology, which could potentially reduce detrimental immune responses to certain drugs. In the course of the Roche-EpiVax collaboration, the EpiVax Tregitope technology will be evaluated for its effect on the immunogenicity (http://www.epivax.com) of protein therapeutics. (PRWeb Dec 2, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/tregitope/protein_therapeutics/prweb3283064.htm">http://www.prweb.com/releases/tregitope/protein_therapeutics/prweb3283064.htm</a></P>]]>
    </description>
</item>
<item>
    <title>H+ Summit 2009: The R/Evolution Of Humanity Plus Technology</title>
    <link>http://www.prweb.com/releases/2009/12/prweb3281774.htm</link>
    <description>
        <![CDATA[  <P>Humanity +  and Mindshare.LA is organizing the H+ Summit a two day interactive event to be held at EON Reality, Inc, that will explore how humanity will be changed by technology in the near future. (PRWeb Dec 2, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/12/prweb3281774.htm">http://www.prweb.com/releases/2009/12/prweb3281774.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Prominent Health Care Executive Joins Stemedica Board Of Directors</title>
    <link>http://www.prweb.com/releases/stemedica-board/anthony-marlon/prweb3281184.htm</link>
    <description>
        <![CDATA[  <P>Anthony M. Marlon, MD was elected to the Stemedica Cell Technologies, Inc. (&#8220;Stemedica&#8221;) Board of Directors at the Company&#8217;s November 20th Board Meeting. (PRWeb Dec 1, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/stemedica-board/anthony-marlon/prweb3281184.htm">http://www.prweb.com/releases/stemedica-board/anthony-marlon/prweb3281184.htm</a></P>]]>
    </description>
</item>
<item>
    <title>PacsDrive Announces Low Cost Medical Imaging Storage Service, Seeks to Alter Status Quo in Health Care IT</title>
    <link>http://www.prweb.com/releases/2009/12/prweb3258934.htm</link>
    <description>
        <![CDATA[  <P>Enterprise level storage is now available to small and medium sized health care providers without breaking the bank. (PRWeb Dec 1, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/12/prweb3258934.htm">http://www.prweb.com/releases/2009/12/prweb3258934.htm</a></P>]]>
    </description>
</item>
<item>
    <title>First Public Showing of Innovative Waste-to-Energy Process </title>
    <link>http://www.prweb.com/releases/2009/12/prweb3262934.htm</link>
    <description>
        <![CDATA[  <P>California waste-to-energy firm claims first place in speed, environmental purity, carbon sequesteration, smallest footprint, salable pure gas, byproducts, and return on invested dollar. (PRWeb Dec 1, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/12/prweb3262934.htm">http://www.prweb.com/releases/2009/12/prweb3262934.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Silicon Valley Veteran Launches New Venture on the &#8220;nanoEdge&#8221; of the Emerging Nanotechnology Revolution</title>
    <link>http://www.prweb.com/releases/nanotechnology/nanoedge/prweb3273754.htm</link>
    <description>
        <![CDATA[  <P>Michael R. Drapp, a 34-year veteran of the high-technology industry, has formed nanoEdge&#8482; Technologies, a business development and intellectual property management company focused on the emerging nanotechnology space.  The company also plans to invest in promising technologies and act as a nanotechnology incubator. (PRWeb Dec 1, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/nanotechnology/nanoedge/prweb3273754.htm">http://www.prweb.com/releases/nanotechnology/nanoedge/prweb3273754.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services</title>
    <link>http://www.prweb.com/releases/top_five_pharma/icardiac/prweb3272134.htm</link>
    <description>
        <![CDATA[  <P>iCardiac now provides services to three out of top five global pharmaceutical companies. (PRWeb Dec 1, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/top_five_pharma/icardiac/prweb3272134.htm">http://www.prweb.com/releases/top_five_pharma/icardiac/prweb3272134.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Mercy Ships and MediSend International Partner to Deliver Hope and Healing</title>
    <link>http://www.prweb.com/releases/2009/12/prweb3272604.htm</link>
    <description>
        <![CDATA[  <P>The two humanitarian organizations will collaborate in comprehensive training programs, including biomedical repair technologies. Their shared efforts will begin in 2010 to benefit the West African country of Togo. (PRWeb Dec 1, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/12/prweb3272604.htm">http://www.prweb.com/releases/2009/12/prweb3272604.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Tepnel Pharmaceutical Services to Offer DNA Genotek&#8217;s Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service</title>
    <link>http://www.prweb.com/releases/2009/12/prweb3275804.htm</link>
    <description>
        <![CDATA[  <P>DNA Genotek, a leading provider of products for biological sample collection, today announced that Tepnel Pharmaceutical Services will offer Oragene&#8226;DNA sample collection kits as part of its nucleic acid extraction and genotyping service. (PRWeb Dec 1, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/12/prweb3275804.htm">http://www.prweb.com/releases/2009/12/prweb3275804.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc.</title>
    <link>http://www.prweb.com/releases/projectaccounting/software/prweb3280154.htm</link>
    <description>
        <![CDATA[  <P>Congruent Software agrees to migrate their Microsoft Dynamics SL clients (including project accounting clients) to Synergy Business Solutions to maintain quality service. (PRWeb Dec 1, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/projectaccounting/software/prweb3280154.htm">http://www.prweb.com/releases/projectaccounting/software/prweb3280154.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch</title>
    <link>http://www.prweb.com/releases/Illinois/IVF/prweb3281404.htm</link>
    <description>
        <![CDATA[  <P>A new clinical study presented to the American Society for Reproductive Medicine shows that three-dimensional (3-D) automated ultrasound follicle measurement using GE&#039;s SonoAVC software during an in vitro fertilization (IVF) cycle is effective and more efficient than traditional manual measurement of the follicles. (PRWeb Dec 1, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/Illinois/IVF/prweb3281404.htm">http://www.prweb.com/releases/Illinois/IVF/prweb3281404.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com</title>
    <link>http://www.prweb.com/releases/charleston_lasik_cataract/dr_kerry_solomon/prweb3281634.htm</link>
    <description>
        <![CDATA[  <P>Dr. Kerry Solomon announced that he has joined Carolina Eyecare Physicians and has launched his redesigned website at www.DrKerrySolomon.com, which was developed by Medical Consulting Group.  Dr. Solomon is a proven LASIK, lens implant, and cataract surgery expert who has been professionally recognized for his substantial contributions to improving vision correction surgery.  He is a member of Trusted LASIK Surgeons, which screens LASIK surgeons based upon experience, professional credentials, and premier patient care in order to ensure only highly qualified surgeons with proven expertise are featured in its online LASIK directory. (PRWeb Dec 1, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/charleston_lasik_cataract/dr_kerry_solomon/prweb3281634.htm">http://www.prweb.com/releases/charleston_lasik_cataract/dr_kerry_solomon/prweb3281634.htm</a></P>]]>
    </description>
</item>
<item>
    <title>Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence</title>
    <link>http://www.prweb.com/releases/2009/11/prweb3262884.htm</link>
    <description>
        <![CDATA[  <P>Exiqon A/S (NASDAQ OMX Copenhagen: &#8220;EXQ&#8221;) announced today that the Harvard Medical School ICCB-Longwood Screening Facility (ICCB-L) has been recognized as a MicroRNA Screening Center of Excellence.  ICCB-L supports investigators at Harvard Medical School, and associated hospitals and institutions, for high-throughput screening of small molecule and RNAi libraries. (PRWeb Nov 30, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/11/prweb3262884.htm">http://www.prweb.com/releases/2009/11/prweb3262884.htm</a></P>]]>
    </description>
</item>
</channel>
</rss>